Roman Fayerberg is a registered patent attorney with broad experience helping clients to strategically protect and leverage their innovations globally. Roman works with clients to develop and manage worldwide patent portfolios and counsels clients in regard to freedom to operate, patent landscape, and patent infringement and validity matters. He also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities.
Roman has represented clients ranging from start-ups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology. He understands the legal goals of each of his clients and develops and executes patent strategies that meet such goals.
Roman is a frequent speaker and author on topics related to patent law. He has been recognized in IAM magazine’s IAM Patent 1000: The World’s Leading Patent Professionals. Roman previously served as a co-chair of the Boston Bar Association’s Intellectual Property Section, and is currently a co-chair of the Medical Device, Diagnostics & Digital Health Committee of the Massachusetts Biotechnology Counsel (MassBio).
Roman’s patent practice builds on his experience as a research and development engineer at C.R. Bard (now Becton Dickinson), where he spent 5 years developing biomaterials-based products for hemostasis and soft tissue reconstruction. His engineering career began at Boston Scientific Corporation, where he designed and developed new products for less invasive neurosurgeries, such as catheters, stents and stent delivery systems.
